JSJacob C. Schwartz

Jacob C. Schwartz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jacob C. Schwartz has a total of 119 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Global Profiling of Remodeled Subcellular Structures Due to Drug Treatment and Disease

    by Rachel A. Victor, Jesse J. Altemus, Michelle A. Lay, Sarah N. Shepherd, Valery F. Thompson, Mozani Zianti, Marco Padilla-Rodriguez, Austin Lipinski, Ghassan Mouneimne, Paul R. Langlais, et al.

    In recent years, knowledge about basic cell biology and biochemistry has been reshaped by new understanding of phase-separated condensates.1,2 The primary mode of containment for cell biochemistry ...

  • Open Access

    Identifying Subcellular Structure Components in Escherichia Coli by Crosslinking and SEC‐MS

    by Rachel A. Victor, Austin Lipinski, Paul R. Langlais, Jacob C. Schwartz

    Cells are comprised of a broad spectrum of structures that compartmentalize biochemical and signaling mechanisms. These structures can be comprised of many biomolecules, but especially lipids, proteins, and nucleic acids. Techniques are limited to quantify or discover new subcellular structures. We explored whether a proteomics approach using chemical crosslinking followed by size‐exclusion chromatography and mass spectrometry (SEC‐MS) of whole cell lysates can address this challenge. Formaldehyde crosslinking was used to preserve the weak molecular interactions responsible for many protein and nucleic acid assemblies. In this study, we perform the first formaldehyde crosslinking‐assisted SEC‐MS in a bacterial system. We demonstrate that when expressed ectopically in E. coli , large structures of a known assembly protein, FUS, can be detected through SEC‐MS. We then show that E. coli proteins are enriched in particles of large or medium size due to formaldehyde crosslinking, which is the first analysis by formaldehyde and SEC‐MS for a bacterial system. Last, analysis identified previously characterized E. coli protein assemblies and condensates, as well as potentially novel associations of prokaryote metabolism with large subcellular bodies. We propose this unbiased method can be used to stimulate or supplement targeted methods for discovery of new cellular bodies in a wide range of cell types.


  • Open Access

    Global Profiling of Remodeled Subcellular Structures Due to Drug Treatment and Disease

    by Rachel A. Victor, Jesse J. Altemus, Michelle A. Lay, Sarah N. Shepherd, Valery F. Thompson, Mozani Zianti, Marco Padilla-Rodriguez, Austin Lipinski, Ghassan Mouneimne, Paul R. Langlais, et al.

    Cellular biochemistry arises from various interactions between macromolecules, including proteins, nucleic acids, and lipids. These make up membrane-bound organelles, membrane-less compartments, and molecular assemblies and scaffolds. Changes due to stimuli or disease can significantly impact cell fate and metabolism. We recently reported our protocol combining crosslinking and size exclusion chromatography with mass spectrometry (SEC-MS). In this study, we explore global changes to subcellular structure in Ewing sarcoma cell lines or in response to drug treatment. Crosslinking-dependent differential enrichment across four human cell lines is seen for proteins involved in splicing, mitochondria function, and cell division. We confirmed changes to nucleoli structure. We also examine structures affected by a transcription inhibitor, flavopiridol. Following flavopiridol treatment, we observed changes to the levels of transcription and mRNA processing machinery present in large subcellular structures. Unexpected effects were also found, including structural changes to a cytoplasmic organelle, the peroxisome. Along with a reduction in peroxisome function, dissociation of peroxisome pore proteins PEX13 and PEX14 was detected by STORM microscopy. We conclude that SEC-MS combined with crosslinking is a valuable method to detect and quantify drug or disease effects on subcellular structures and may shed light on new aspects to mechanisms underlying their biologic outcomes. Graphical Key Points: Crosslinking plus SEC-MS shows global effects on subcellular structure in disease and treatment. Ewing sarcoma cell lines tested present distinct molecular composition in splicing, mitochondria, and nucleoli. A transcription inhibitor flavopiridol disrupts peroxisome function and protein import pores

  • Open Access

    Purification of Low‐Complexity Domain Proteins FUS, EWSR1, and Their Fusions

    by Jesse J. Altemus, Michelle A. Lay, Valery F. Thompson, Jacob C. Schwartz

    FET proteins are large multifunctional proteins that have several key roles in biology. The FET family of proteins, including FUS, EWSR1, and TAF15, play critical roles in transcription regulation, RNA processing, and DNA damage repair. These multifunctional RNA‐ and DNA‐binding proteins are ubiquitously expressed and conserved across vertebrate species. They contain low‐complexity (LC) domains that allow them to assemble and phase separate but also makes the proteins prone to aggregation. Aberrations in FET proteins, such as point mutations, aggregation, or translocations leading to fusion proteins, have been implicated in several pathologies, including frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS), and Ewing sarcoma. In vitro study of FET proteins is hampered by their propensity to aggregate, their disordered structure, and their susceptibility to proteolysis, making high‐yield production difficult. Here, we present optimized methods for the purification of full‐length FUS, EWSR1, and their fusion proteins. These protocols enable researchers to overcome issues related to aggregation and solubility, facilitating biochemical and biophysical studies of these critical yet complex proteins. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.Basic Protocol: Purification of EWSR1 and FUS proteinsAlternate Protocol: Purification for fusion proteins


  • Open Access

    Ewing Sarcoma Related protein 1 recognizes R‐loops by binding DNA forks

    by Michelle A. Lay, Valery F. Thompson, Ajibola D. Adelakun, Jacob C. Schwartz

    EWSR1 (Ewing Sarcoma Related protein 1) is an RNA binding protein that is ubiquitously expressed across cell lines and involved in multiple parts of RNA processing, such as transcription, splicing, and mRNA transport. EWSR1 has also been implicated in cellular mechanisms to control formation of R‐loops, a three‐stranded nucleic acid structure consisting of a DNA:RNA hybrid and a displaced single‐stranded DNA strand. Unscheduled R‐loops result in genomic and transcription stress. Loss of function of EWSR1 functions commonly found in Ewing Sarcoma correlates with high abundance of R‐loops. In this study, we investigated the mechanism for EWSR1 to recognize an R‐loop structure specifically. Using electrophoretic mobility shift assays (EMSA), we detected the high affinity binding of EWSR1 to substrates representing components found in R‐loops. EWSR1 specificity could be isolated to the DNA fork region, which transitions between double‐ and single‐stranded DNA. Our data suggests that the Zinc‐finger domain (ZnF) with flanking arginine and glycine rich (RGG) domains provide high affinity binding, while the RNA recognition motif (RRM) with its RGG domains offer improved specificity. This model offers a rational for EWSR1 specificity to encompass a wide range in contexts due to the DNA forks always found with R‐loops.


  • Open Access

    Ewing Sarcoma Related protein 1 recognizes R-loops by binding DNA forks

    by Michelle A. Lay, Valery F. Thompson, Ajibola D. Adelakun, Jacob C. Schwartz

    EWSR1 (Ewing Sarcoma Related protein 1) is an RNA binding protein that is ubiquitously expressed across cell lines and involved in multiple parts of RNA processing, such as transcription, splicing, and mRNA transport. EWSR1 has also been implicated in cellular mechanisms to control formation of R-loops, a three-stranded nucleic acid structure consisting of a DNA:RNA hybrid and a displaced single-stranded DNA strand. Unscheduled R-loops result in genomic and transcription stress. Loss of function of EWSR1 functions commonly found in Ewing Sarcoma correlates with high abundance of R-loops. In this study, we investigated the mechanism for EWSR1 to recognize an R-loop structure specifically. Using electrophoretic mobility shift assays (EMSA), we detected the high affinity binding of EWSR1 to substrates representing components found in R-loops. EWSR1 specificity could be isolated to the DNA fork region, which transitions between double- and single-stranded DNA. Our data suggests that the Zinc-finger domain (ZnF) with flanking arginine and glycine rich (RGG) domains provide high affinity binding, while the RNA recognition motif (RRM) with its RGG domains offer improved specificity. This model offers a rational for EWSR1 specificity to encompass a wide range in contexts due to the DNA forks always found with R-loops.

  • Open Access

    Binding of the nuclear ribonucleoprotein family member FUS to RNA prevents R-loop RNA:DNA hybrid structures

    by Valery F. Thompson, Daniel R. Wieland, Vivian Mendoza-Leon, Helen I. Janis, Michelle A. Lay, Lucas M. Harrell, Jacob C. Schwartz


  • Open Access

    FUS binding to RNA prevents R-loops

    by Valery F. Thompson, Daniel R. Wieland, Vivian Mendoza-Leon, Helen I. Janis, Michelle A. Lay, Lucas M. Harrell, Jacob C. Schwartz

    The protein FUS (FUSed in sarcoma) is a metazoan RNA-binding protein that influences RNA production by all three nuclear polymerases. FUS also binds nascent transcripts, RNA processing factors, RNA polymerases, and transcription machinery. We explored the role of FUS binding interactions for activity during transcription. In vitro run-off transcription assays revealed FUS enhanced RNA produced by a non-eukaryote polymerase. Activity also reduced the formation of R-loops between RNA products and their DNA template. Analysis by domain mutation and deletion indicated RNA-binding was required for activity. We interpret that FUS binds and sequesters nascent transcripts to prevent R-loops forming with nearby DNA. DRIP-seq analysis showed that a knockdown of FUS increased R-loop enrichment near expressed genes. Prevention of R-loops by FUS binding to nascent transcripts has potential to affect transcription by any RNA polymerase, highlighting the broad impact FUS can have on RNA metabolism in cells and disease.


  • Open Access

    Fusion protein EWS-FLI1 is incorporated into a protein granule in cells

    by Nasiha S. Ahmed, Lucas M. Harrell, Daniel R. Wieland, Michelle A. Lay, Valery F. Thompson, Jacob C. Schwartz

    Ewing sarcoma is driven by fusion proteins containing a low-complexity (LC) domain that is intrinsically disordered and a powerful transcriptional regulator. The most common fusion protein found in Ewing sarcoma, EWS-FLI1, takes its LC domain from the RNA-binding protein EWSR1 (Ewing sarcoma RNA-binding protein 1) and a DNA-binding domain from the transcription factor FLI1 (Friend leukemia virus integration 1). EWS-FLI1 can bind RNA polymerase II (RNA Pol II) and self-assemble through its LC domain. The ability of RNA-binding proteins like EWSR1 to self-assemble or phase separate in cells has raised questions about the contribution of this process to EWS-FLI1 activity. We examined EWSR1 and EWS-FLI1 activity in Ewing sarcoma cells by siRNA-mediated knockdown and RNA-seq analysis. More transcripts were affected by the EWSR1 knockdown than expected and these included many EWS-FLI1 regulated genes. We reevaluated physical interactions between EWS-FLI1, EWSR1, and RNA Pol II, and used a cross-linking-based strategy to investigate protein assemblies associated with the proteins. The LC domain of EWS-FLI1 was required for the assemblies observed to form in cells. These results offer new insights into a protein assembly that may enable EWS-FLI1 to bind its wide network of protein partners and contribute to regulation of gene expression in Ewing sarcoma.


  • Open Access

    Isolating and Analyzing Protein Containing Granules from Cells

    by Rachel A. Victor, Valery F. Thompson, Jacob C. Schwartz

    Recent advancements in detection methods have made protein condensates, also called granules, a major area of study, but tools to characterize these assemblies need continued development to keep up with evolving paradigms. We have optimized a protocol to separate condensates from cells using chemical cross‐linking followed by size‐exclusion chromatography (SEC). After SEC fractionation, the samples can be characterized by a variety of approaches including enzyme‐linked immunosorbent assay, dynamic light scattering, electron microscopy, and mass spectrometry. The protocol described here has been optimized for cultured mammalian cells and E. coli expressing recombinant proteins. Since the lysates are fractionated by size, this protocol can be modified to study other large protein assemblies, including the nuclear pore complex, and for other tissues or organisms. © 2021 Wiley Periodicals LLC.This article was corrected on 20 July 2022. See the end of the full text for details.Basic Protocol 1: SEC separation of cross‐linked mammalian cell lysatesAlternate Protocol: Preparation of non‐crosslinked mammalian cellsBasic Protocol 2: SEC separation of E. coli lysateSupport Protocol 1: Detecting protein of interest by ELISASupport Protocol 2: TCA precipitation of SEC fractions